Advanced Management of the Dermatologic Manifestations of Lupus

The presentation discusses advancements in managing dermatological manifestations of lupus, particularly cutaneous lupus. The speaker, acknowledging pivotal researchers in the field, outlines a treatment algorithm that starts with education on sun protection and topical treatments, progressing to antimalarial medications like hydroxychloroquine and chloroquine. Second-line treatments include immunosuppressants such as mycophenolate and methotrexate, both shown to have similar efficacy. The talk also highlights newer therapies like Lenalidomide and biologics such as bellumab and anapholumab, with emphasis on recent clinical findings showing effectiveness in treating severe cases of cutaneous lupus. The speaker notes ongoing research into new medications, including ducrevacitinib and litofilumab, which show promising results in trial settings. Case studies illustrate the management strategies involving varied treatments tailored to individual patient responses, underscoring the importance of ongoing innovation and research in this challenging area of dermatology. Overall, antimalarials remain the cornerstone of treatment, with emerging therapies providing additional options for patients not responding to conventional treatments.